1. |
Alexopoulos H, Dalakas MC. The immunobiology of autoimmune encephalitides. J Autoimmun, 2019, 104: 102339.
|
2. |
Co DO, Kwon JM. Autoimmune encephalitis: distinguishing features and specific therapies. Crit Care Clin, 2022, 38(2): 393-412.
|
3. |
Schieveld J, Strik J, van Kraaij S, et al. Psychiatric manifestations and psychopharmacology of autoimmune encephalitis: a multidisciplinary approach. Handb Clin Neurol, 2019, 165: 285-307.
|
4. |
Chen L, Zhu L, Lu D, et al. Association between autoimmune encephalitis and epilepsy: systematic review and meta-analysis. Seizure, 2021, 91: 346-359.
|
5. |
Cucuzza ME, Pavone P, D'Ambra A, et al. Autoimmune encephalitis and CSF anti-AMPA GluR3 antibodies in childhood: a case report and literature review. Neurol Sci, 2022, 43(9): 5237-5241.
|
6. |
Ford H, Griffith S, Warren N, et al. Psychiatric manifestations of autoimmune encephalitis. Autoimmun Rev, 2022, 21(9): 103145.
|
7. |
Dutra LA, Abrantes F, Toso FF, et al. Autoimmune encephalitis: a review of diagnosis and treatment. Arq Neuropsiquiatr, 2018, 76(1): 41-49.
|
8. |
Esposito S, Principi N, Calabresi P, et al. An evolving redefinition of autoimmune encephalitis. Autoimmun Rev, 2019, 18(2): 155-163.
|
9. |
Pruss H. Pathophysiology and prognostic factors of autoimmune encephalitis. Fortschr Neurol Psychiatr, 2016, 84(5): 264-270.
|
10. |
Jafarpour S, Santoro JD. Autoimmune encephalitis. Pediatr Rev, 2022, 43(4): 198-211.
|
11. |
Blattner MS, Day GS. Sleep disturbances in patients with autoimmune encephalitis. Curr Neurol Neurosci Rep, 2020, 20(7): 28.
|
12. |
Ciano-Petersen NL, Muniz-Castrillo S, Vogrig A, et al. Immunomodulation in the acute phase of autoimmune encephalitis. Rev Neurol (Paris), 2022, 178(1-2): 34-47.
|
13. |
Uy CE, Binks S, Irani SR. Autoimmune encephalitis: clinical spectrum and management. Pract Neurol, 2021, 21(5): 412-423.
|
14. |
Hebert J, Muccilli A, Wennberg RA, et al. Autoimmune encephalitis and autoantibodies: a review of clinical implications. J Appl Lab Med, 2022, 7(1): 81-98.
|
15. |
Broadley J, Seneviratne U, Beech P, et al. Prognosticating autoimmune encephalitis: a systematic review. J Autoimmun, 2019, 96: 24-34.
|
16. |
Zhu S, Yu J, Wu Y, et al. Pathophysiology and clinical management of autoimmune encephalitis-associated seizures. Neuroimmunomodulation, 2022, 20: 1-14.
|
17. |
李学斌, 杨灿, 李秋波. 抗N-甲基-D-天门冬氨酸受体脑炎病理机制的研究进展. 中风与神经疾病杂志, 2023, 40(4): 382-384.
|
18. |
Boesen MS, Born AP, Lydolph MC, et al. Pediatric autoimmune encephalitis in Denmark during 2011-17: a nationwide multicenter population-based cohort study. Eur J Paediatr Neurol, 2019, 23(4): 639-652.
|
19. |
Endres D, Leypoldt F, Bechter K, et al. Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations. Eur Arch Psychiatry Clin Neurosci, 2020, 270(7): 803-818.
|
20. |
Ellul M A, Wood G, Tooren H, et al. Update on the diagnosis and management of autoimmune encephalitis. Clin Med (Lond), 2020, 20(4): 389-392.
|
21. |
Pruss H. Postviral autoimmune encephalitis: manifestations in children and adults. Curr Opin Neurol, 2017, 30(3): 327-333.
|
22. |
Chen B, Lopez C A, Sirven J I, et al. Autoimmune encephalitis-related seizures and epilepsy: diagnostic and therapeutic approaches. Mayo Clin Proc, 2021, 96(8): 2029-2039.
|
23. |
Trewin BP, Freeman I, Ramanathan S, et al. Immunotherapy in autoimmune encephalitis. Curr Opin Neurol, 2022, 35(3): 399-414.
|
24. |
Kunchok A, McKeon A, Zekeridou A, et al. Autoimmune/paraneoplastic encephalitis antibody biomarkers: frequency, age, and sex associations. Mayo Clin Proc, 2022, 97(3): 547-559.
|
25. |
Seery N, Butzkueven H, O'Brien TJ, et al. Rare antibody-mediated and seronegative autoimmune encephalitis: an update. Autoimmun Rev, 2022, 21(7): 103118.
|
26. |
Liang C, Chu E, Kuoy E, et al. Autoimmune-mediated encephalitis and mimics: a neuroimaging review. J Neuroimaging, 2022, 15: 256-261.
|
27. |
Hara M, Arino H, Petit-Pedrol M, et al. DPPX antibody-associated encephalitis: main syndrome and antibody effects. Neurology, 2017, 88(14): 1340-1348.
|
28. |
Spatola M, Sabater L, Planaguma J, et al. Encephalitis with mGluR5 antibodies: symptoms and antibody effects. Neurology, 2018, 90(22): e1964-e1972.
|
29. |
Dade M, Berzero G, Izquierdo C, et al. Neurological syndromes associated with anti-GAD antibodies. Int J Mol Sci, 2020, 21(10): 361-365.
|